| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |